BERKELEY, Calif.--(BUSINESS WIRE)--Acrigen Biosciences, Inc. (“Acrigen”), an early-stage biotechnology company developing precision gene editing technology and genetic medicines, today announced its ...

The images show how tumors appear to a surgeon using Blaze Bioscience’s “tumor paint.” Rows A and B represent two images taken at different times during the surgery. The first column shows the tumor ...

Evercrisp Biosciences, Inc., a portfolio company of Apple Tree Partners, entered bankruptcy within a month of a filing by ...